These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 12899009

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Influence of anti-tuberculosis drug resistance on the treatment outcome of pulmonary tuberculosis patients receiving DOTS in Riyadh, Saudi Arabia.
    Singla R, Al-Sharif N, Al-Sayegh MO, Osman MM, Shaikh MA.
    Int J Tuberc Lung Dis; 2002 Jul; 6(7):585-91. PubMed ID: 12102297
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Spread of drug-resistant strains of mycobacterium tuberculosis among patients with isolated bacteria].
    Zhukova MP.
    Probl Tuberk; 1998 Jul; (1):14-6. PubMed ID: 9553424
    [Abstract] [Full Text] [Related]

  • 6. Impact of country of origin on drug-resistant tuberculosis among foreign-born persons in British Columbia.
    Moniruzzaman A, Elwood RK, Schulzer M, FitzGerald JM.
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):844-50. PubMed ID: 16898367
    [Abstract] [Full Text] [Related]

  • 7. Rifampicin mono-resistant Mycobacterium tuberculosis in Bujumbura, Burundi: results of a drug resistance survey.
    Sanders M, Van Deun A, Ntakirutimana D, Masabo JP, Rukundo J, Rigouts L, Fissette K, Portaelst F.
    Int J Tuberc Lung Dis; 2006 Feb; 10(2):178-83. PubMed ID: 16499257
    [Abstract] [Full Text] [Related]

  • 8. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
    Belianin II, Shmelev EI.
    Probl Tuberk Bolezn Legk; 2004 Feb; (7):32-5. PubMed ID: 15379039
    [Abstract] [Full Text] [Related]

  • 9. [Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].
    Zinov'ev IP, Esaulova NA, Novikov VG, Kokovikhina IA.
    Probl Tuberk Bolezn Legk; 2009 Feb; (4):37-9. PubMed ID: 19514452
    [Abstract] [Full Text] [Related]

  • 10. [Efficacy of chemotherapy for tuberculosis in patients who isolate drug-resistant strains of M. tuberculosis with different genotypes].
    Vasil'eva IA, Andreevskaia SN, Smirnova TG, Chernousova LI, Chukanov VI.
    Probl Tuberk Bolezn Legk; 2004 Feb; (8):25-8. PubMed ID: 15478554
    [Abstract] [Full Text] [Related]

  • 11. [Analysis of risk factors of the occurrence of drug resistance in patients with tuberculosis from civil and penitentiary sectors in the Samara Region].
    Balabanova IaM, Raddi M, Gram K, Malomanova NA, Elizarova ED, Kuznetsov SI, Gusarova GI, Zakharova SM, Melent'ev AS, Kriukova EG, Fedorin IM, Golyshevskaia VI, Dorozhkova IR, Shilova MV, Erokhin VV, Drobnevskiĭ F.
    Probl Tuberk Bolezn Legk; 2005 Feb; (5):25-31. PubMed ID: 15988974
    [Abstract] [Full Text] [Related]

  • 12. First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.
    Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P, Tabarsi P, Amiri MV, Mirsaeidi M, Mansouri D, Masjedi MR, Velayati AA.
    Int J Infect Dis; 2009 Sep; 13(5):e236-40. PubMed ID: 19285897
    [Abstract] [Full Text] [Related]

  • 13. Treatment outcome of relapse and defaulter pulmonary tuberculosis patients.
    Sevim T, Ataç G, Güngör G, Törün I, Aksoy E, Gemci, Tahaoglu K.
    Int J Tuberc Lung Dis; 2002 Apr; 6(4):320-5. PubMed ID: 11936741
    [Abstract] [Full Text] [Related]

  • 14. [Artificial pneumoperitoneum in the complex treatment of pulmonary tuberculosis patients isolating drug-resistant mycobacterium tuberculosis].
    Bagdasarian TR, Vasil'eva IA, Sigaev AT, Chukanov VI.
    Probl Tuberk Bolezn Legk; 2006 Apr; (8):23-6. PubMed ID: 17002053
    [Abstract] [Full Text] [Related]

  • 15. [Resistance of Mycobacterium tuberculosis strains isolated from patients to antituberculosis drugs].
    Sybirna RI, Iavors'ka GV.
    Mikrobiol Z; 2001 Apr; 63(4):91-5. PubMed ID: 11692684
    [Abstract] [Full Text] [Related]

  • 16. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
    Khudushina TA, Voloshina EP, Adamovich NV, Maslakova MG, Terekhova ND.
    Probl Tuberk Bolezn Legk; 2005 Apr; (12):37-9. PubMed ID: 16496762
    [Abstract] [Full Text] [Related]

  • 17. [A role of the biological chip test in the determination of rifampicin resistance in Mycobacteria in adolescents with active pulmonary tuberculosis].
    Firsova VA, Poluektova FG, Kuz'min AV, Chernousova LN.
    Probl Tuberk Bolezn Legk; 2004 Apr; (8):28-30. PubMed ID: 15478555
    [Abstract] [Full Text] [Related]

  • 18. [Epidemiological, clinical and biological profile of resistant or recurrent pulmonary tuberculosis in Abidjan].
    Kouassi B, Horo K, N'douba KA, Koffi N, Ngom A, Aka-Danguy E, Dosso M.
    Bull Soc Pathol Exot; 2004 Apr; 97(5):336-7. PubMed ID: 15787267
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
    Asmamaw D, Seyoum B, Makonnen E, Atsebeha H, Woldemeskel D, Yamuah L, Addus H, Aseffa A.
    Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.